Johnson & Johnson Recalls 33,000 Baby Powder Bottles After FDA Finds Asbestos In Sample.

Johnson & Johnson recalled 33,000 bottles of baby powder after FDA found trace amounts of asbestos in one of its bottles.

Pharmaceutical giant Johnson & Johnson recalled 33,000 bottles of baby powder on Friday after the U.S. Food and Drug Administration (FDA) found trace amounts of asbestos in one of its bottles. It is said that one of its bottle purchase online contains asbestos.

Johnson & Johnson
Photo Source: CNBC

According to the article of ABS-CBN, This is the first time that Johnson & Johnson has needed to recall its baby powder over asbestos concerns. Asbestos is a known carcinogen that has been linked to deadly mesothelioma.

The recall is the latest blow to the more than 130-year-old US healthcare conglomerate that is facing thousands of lawsuits over a variety of products, including baby powder, opioids, medical devices, and the antipsychotic Risperdal

The company noted that the amount of asbestos detected was minuscule and it is looking at how any could get into its supply. In fact, the levels found were smaller than 0.00002 percent of the content of the bottle.

Based on the article, J& Jfaces more than 15,000 lawsuits from consumers claiming its talc products, including Johnson’s Baby Powder, caused their cancer. The company is investigating to see if the bottle is counterfeit if the plastic safety seal was broken, or where any cross-contamination may have occurred.

A jury last week ordered the company to pay $8 billion to a plaintiff in a case claiming downplayed the risks of Risperdal. That award is not expected to stand, the company and legal experts have said.

The company has already settled some claims over its role in the opioid crisis. It is fighting others. Earlier this month, the company was ordered to pay $8 billion for playing down the risks associated with Risperdal, an anti-psychotic drug.

What can you say about this? Just feel free to leave your comments and reactions to this article.

Leave a Comment